在转移性NSCLC中,患者报告的症状和生活质量与Sacituzumab Govitecan对比Docetaxel:第3期,随机EVOKE-01试验
Niels Reinmuth1, Sébastien Couraud2, Luis Paz-Ares3
1Asklepios Lung Clinic, German Center for Lung Research (DZL), Munich-Gauting, Germany.
JTO clinical and research reports
|January 26, 2026
概括
在转移性NSCLC患者中,sacituzumab govitecan (SG) 与dcetaxel相比,改善了与健康相关的生活质量 (HRQoL). 这表明,在先前的疗法之后,SG是一种有益的治疗选择.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 生活质量研究 研究 生命质量研究
背景情况:
- 在EVOKE-01试验中,在先前接受基化疗和PD-1/PD-L1抑制剂治疗的转移性非小细胞肺癌 (NSCLC) 患者中,研究了sacituzumab govitecan (SG) 与 docetaxel.
- 虽然整体存活率和耐受性显示了SG的数值改善,但没有达到统计学意义.
研究的目的:
- 评估第三阶段EVOKE-01试验中的与健康相关的生活质量 (HRQoL) 数据.
- 为了比较用SG治疗的患者和用dcetaxel治疗的患者之间的HRQoL结果.
主要方法:
- 603名患有转移性NSCLC的患者被随机分配1:1接受SG或dcetaxel在21天周期中.
- 通过使用NSCLC症状评估问卷 (NSCLC-SAQ),EORTC QLQ-C30和EQ-5D-3L问卷来评估HRQoL.
- 分析包括25周与基线的最小平方平均变化,第一次有意义的恶化或死亡的时间,以及确认恶化的时间.
主要成果:
- SG在特定的HRQoL指标上显示出明显更好的效果,包括呼吸短促,疲劳和NSCLC-SAQ的整体得分.
- 根据QLQ-C30的测量,SG还显示了角色功能,疲劳和呼吸障碍的改善.
- 时间到第一个有意义的恶化或死亡有利于SG跨多个HRQoL终点,包括NSCLC-SAQ和QLQ-C30措施,和EuroQol视觉模拟尺度.
结论:
- 探索性结果表明,sacituzumab govitecan在这个患者群体中可能比dcetaxel提供更好的HRQoL益处.
- 这些发现支持SG作为转移性NSCLC患者的活性治疗剂,这些患者已经在以为基础的化疗和PD-1/PD-L1抑制剂治疗中取得进展.
关键词:
多塞塔克塞尔 (Docetaxel) 是一种药物.在NSCLCLC中,我们可以看到.患者报告的结果.生活质量生活的质量.萨西图祖马布 (Sacituzumab) govitecan也可以使用.更多相关视频
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.6K
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.8K
相关概念视频
Half-life of a Reaction
38.8K
The half-life of a reaction (t1/2) is the time required for one-half of a given amount of reactant to be consumed. In each succeeding half-life, half of the remaining concentration of the reactant is consumed. For example, during the decomposition of hydrogen peroxide, during the first half-life (from 0.00 hours to 6.00 hours), the concentration of H2O2 decreases from 1.000 M to 0.500 M. During the second half-life (from 6.00 hours to 12.00 hours), the concentration decreases from 0.500 M to...
38.8K
Characteristics of Life
257.7K
Biology is a natural science that studies life and living organisms, including their structure, function, development, interactions, evolution, distribution, and taxonomy. The field's scope is extensive and divided into several specialized disciplines, such as anatomy, physiology, ethology, genetics, and many more. All living things share a few key traits, including cellular organization, heritable genetic material and the ability to adapt/evolve, metabolism to regulate energy needs, the...
257.7K
Data Reporting and Recording
5.4K
Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.4K
The Angiosperm Life Cycle
72.2K
Plants have a life cycle split between two multicellular stages: a haploid stage—with cells containing one set of chromosomes—and a diploid stage—with cells containing two sets of chromosomes. The haploid stage is the gamete-producing gametophyte, and the diploid stage is the spore-producing sporophyte.
72.2K
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
